Advertisement

Topics

Boston Biomedical, Inc. Company Profile

10:29 EST 11th December 2018 | BioPortfolio

Boston Biomedical, Inc. (Founder, Chairman, CEO and CMO: Chiang J. Li, M.D. FACP) was founded in November, 2006 and is a privately-held biotechnology company focused on the research and development of novel cancer therapeutics. Boston Biomedical has developed a world-leading product pipeline targeting cancer stem cells. Boston Biomedical’s innovation in drug discovery has received a number of recognitions and awards in the United States, including sole recipient of the Frost & Sullivan 2010 North American Drug Discovery Technology Innovation of the Year Award, and a 2011 Biotech Pioneer Award (Alexandria Oncology Summit). Boston Biomedical is headquartered in Norwood, Massachusetts, USA. Boston Biomedical is financially supported by Mitsui & Co. Global Investment, Alexandria Real Estate Equities, Inc. Contact: Wei Li, Ph.D. wli@bostonbiomedical.com, 781-769-0984; Eric Goldman(917-322-2563)egoldman@rxir.com


News Articles [692 Associated News Articles listed on BioPortfolio]

Boston Biomedical doses first patient in Phase l trial of DSP-0509

Boston Biomedical has dosed the first patient in a Phase l clinical trial to test the safety and pharmacokinetic of...Read More... The post Boston Biomedical doses first patient in Phase l trial of DS...

Boston Biomedical reports detailed data from Phase III gastric cancer trial of napabucasin

HIPAA Settlements: Three Boston Hospitals Pay $1M in Fines for “Boston Med” Filming

Heather Landi, Associate EditorThree Boston hospitals that allowed film crews to film “Boston Med” on premises have settled with the U.S. Department of Health and Human Services, Office for Civil ...

Boston Medical Center, Boston University receive $1.58M CDC grant in efforts to reduce fetal alcohol spectrum disorders

(Boston Medical Center) A new collaborative program led by Boston Medical Center (BMC) and funded by the Centers for Disease Control and Prevention (CDC), will train healthcare providers on how to be...

Massachusetts healthcare turmoil: I’m quoted in the Boston Globe and Boston Herald

I’m always happy to speak with the press to provide my take on healthcare business and policy. In the last few days I’ve been quoted in a few outlets: Today’s Boston Globe: In a sudd...

Aerie Pharmaceuticals and DSM Biomedical Expand Collaboration Agreement

Aerie Pharmaceuticals (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with ope...

New Bionow Service Company of the Year Award to recognise excellence in specialist biomedical service provision and submission deadline extension

Applications are invited from specialist biomedical service companies who meet the criteria detailed in the award application form available at http://www.bionow.co.uk/events/bionowannualawardsdinner....

Boston Globe and Boston Herald quote David Williams on Harvard Pilgrim CEO departure

Boston Globe: In a sudden departure, Harvard Pilgrim CEO resigns amid questions about his behavior Harvard Pilgrim and Partners each said Tuesday that Schultz’s resignation does not affect their dis...

PubMed Articles [350 Associated PubMed Articles listed on BioPortfolio]

Boston type I keratoprosthesis implantation technique : Video article.

Keratoprosthetics refer to the replacement of human corneal tissue with an artificially produced exchange product. The most widely implanted keratoprosthesis worldwide is the Boston Type I Keratopros...

Comparative Outcomes of Boston Keratoprosthesis Type 1 Implantation Based on Vision in the Contralateral Eye.

To compare the outcomes of Boston keratoprosthesis type 1 implantation after failed keratoplasty in patients who are blind or sighted in the contralateral eye.

Long-term outcomes with Boston type 1 keratoprosthesis in ocular burns.

To evaluate the long-term outcomes of Boston type I keratoprosthesis (B-Kpro) in the management of patients with ocular burn injuries.

Intraocular Light Scatter in Eyes With the Boston Type 1 Keratoprosthesis.

The Boston keratoprosthesis (KPro) is the most commonly used artificial cornea. It has been proven to be successful for severe corneal disease not amenable to keratoplasty. We have observed our patien...

The Perfect and Famous Anesthetic Known as Methyl in Boston in 1895.

Extravagant claims were made for proprietary dental anesthetics in Boston, MA, in the late 1800s. For instance, in 1883, Urial K. Mayo introduced an inhaled Vegetable Anaesthetic comprised of nitrous ...

Clinical Trials [301 Associated Clinical Trials listed on BioPortfolio]

How Participants Perceive Biomedical Research in Pulmonology

The primary objective of this study is to determine how biomedical research is perceived by patients already participating in a pulmonology research project.

Safety & Performance Study of Lumen Biomedical's FiberNet Distal Protection System for the Treatment of Renal Artery Stenosis

To evaluate the procedural safety and filter efficiency of the FiberNet® Embolic Protection System when used in conjunction with the Boston Scientific Express SD Stent System for primary ...

The Boston Scientific ENOVUS Trial

A prospective, actively controlled, consecutively enrolling, non-randomized multi center clinical evaluation of the safety and efficacy of the Boston Scientific ENOVUS AAA Endograft when u...

Boston Scientific COMET Wire Validation Study

Summary of Study Aims To assess, in a randomised fashion: 1. performance of Boston Scientific Pressure Wire versus St Jude Pressure Wire 2. performance of Boston Scientific Pr...

Bigfoot Biomedical Clinical Research Center (CRC) Trial

The trial is designed to assess safety and feasibility of the Bigfoot Biomedical Type 1 Diabetes Management System (T1DMS) in up to 50 participants in a closely monitored Clinical Research...

Companies [1042 Associated Companies listed on BioPortfolio]

Boston Biomedical, Inc.

Boston Biomedical, Inc. (Founder, Chairman, CEO and CMO: Chiang J. Li, M.D. FACP) was founded in November, 2006 and is a privately-held biotechnology company focused on the resear...

Boston Biomedical Associates

Boston Biomedical Associates has extensive expertise in guiding companies through the regulatory approval process, as well as post market activities (e.g. MDR, vigilance reporting...

Boston Biomedical Consultants, Inc.

Boston Biomedical Consultants, Inc. (BBC) has been a trusted provider of consulting services to the In Vitro Diagnostics (IVD) industry for more than 25 years. A recognized leader in market assessment...

Boston Biomedical Research Institute

The Boston Globe

Boston Globe Media Partners, LLC provides news and information, entertainment, opinion and analysis through its multimedia properties. BGMP includes The Boston Globe, BostonGlobe....

More Information about "Boston Biomedical, Inc." on BioPortfolio

We have published hundreds of Boston Biomedical, Inc. news stories on BioPortfolio along with dozens of Boston Biomedical, Inc. Clinical Trials and PubMed Articles about Boston Biomedical, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Boston Biomedical, Inc. Companies in our database. You can also find out about relevant Boston Biomedical, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record